Close



Apr 17, 2024 06:31AM
Apr 17, 2024 06:30AM
Apr 11, 2024 06:30AM
Feb 28, 2024 06:30AM
Feb 14, 2024 06:30AM
Jan 31, 2024 06:30AM
Jan 8, 2024 06:33AM SAGE Therapeutics (SAGE) Announces Board Changes
Jan 8, 2024 06:32AM
Jan 8, 2024 06:30AM
Dec 14, 2023 06:31AM
Dec 14, 2023 06:30AM
Nov 7, 2023 06:30AM
Oct 18, 2023 06:30AM
Oct 18, 2023 06:30AM Sage Therapeutics Announces U.S. Food and Drug Administration Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
Sep 1, 2023 10:00PM
Aug 31, 2023 06:30AM
Aug 31, 2023 06:30AM
Aug 27, 2023 09:00PM
Aug 8, 2023 07:41AM
Aug 7, 2023 04:56PM
Aug 7, 2023 12:44PM Sage tumbles to record low on clinical depression pill setback
Aug 7, 2023 07:12AM
Aug 7, 2023 07:04AM
Aug 7, 2023 06:47AM
Aug 7, 2023 06:30AM
Aug 7, 2023 06:24AM
Aug 4, 2023 10:42PM
May 2, 2023 06:36AM SAGE Therapeutics (SAGE) Reports Q1, Provides Pipeline and Business Progress
May 2, 2023 06:30AM
Mar 16, 2023 06:30AM
Mar 8, 2023 06:30AM
Feb 22, 2023 06:31AM
Feb 22, 2023 06:31AM
Feb 22, 2023 06:30AM
Feb 16, 2023 12:52PM Sage Therapeutics (SAGE) PT Raised to $60 at Stifel
Feb 16, 2023 06:30AM
Feb 6, 2023 06:51AM
Feb 6, 2023 06:30AM
Feb 6, 2023 06:30AM
Feb 6, 2023 06:30AM
Jan 8, 2023 12:00PM
Dec 6, 2022 06:30AM Sage Therapeutics and Biogen Complete Rolling Submission of New Drug Application for Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Nov 22, 2022 07:00AM
Nov 8, 2022 06:30AM
Nov 1, 2022 07:30AM
Nov 1, 2022 07:30AM
Nov 1, 2022 05:33AM
Oct 17, 2022 06:33AM
Oct 17, 2022 06:30AM Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) Congress
Sep 19, 2022 06:30AM

251,609 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All